oppn’s members advance the field of pathology for the delivery of precision medicine in cancer.

Membership in oppn’s network enables access to cutting-edge technologies and business opportunities through our network of partnerships with health systems, pharmaceutical companies, and the nation’s leading payors.

Our pathologists embrace technology to deliver market-leading turnaround times compatible with informed first-line therapy decisions for oncologists and patients. We place pathologists where they should be: at the center of the clinical decision pathway.